Atlantic Central Enterprises Ltd. owns patents of trans dermal drug delivery and skin permeation technology. The firm is engaged in electromedical and electrotherapeutic apparatus manufacturing.
How did ALCN's recent EPS compare to expectations?
The most recent EPS for Atlantic Central Enterprises Ltd is $, expectations of $.
How did Atlantic Central Enterprises Ltd ALCN's revenue perform in the last quarter?
Atlantic Central Enterprises Ltd revenue for the last quarter is $
What is the revenue estimate for Atlantic Central Enterprises Ltd?
According to of Wall street analyst, the revenue estimate of Atlantic Central Enterprises Ltd range from $ to $
What's the earning quality score for Atlantic Central Enterprises Ltd?
Atlantic Central Enterprises Ltd has a earning quality score of /. The score is based on a four dimension of Profitability, Growth, Cash generation & Capital Allocation, and Leverage.
When does Atlantic Central Enterprises Ltd report earnings?
Atlantic Central Enterprises Ltd next earnings report is expected in
What are Atlantic Central Enterprises Ltd's expected earnings?
Atlantic Central Enterprises Ltd expected earnings is $, according to wall-street analysts.
Did Atlantic Central Enterprises Ltd beat earnings expectations?
Atlantic Central Enterprises Ltd recent earnings of $ expectations.